semaglutide compounding fda Hims & Hers stock falls 25% as curtails compounded GLP-1s FDA crackdown on off-brand Ozempic

In some cases, compounders may be using salt forms of semaglutide, including semaglutide sodium and semaglutide acetate

Investigators reported that 45.3% of participants on the 12 mg arm achieved 30% body-weight reduction over the 80-week trial period [1][2]

And so, scientists like Murielle Vniant-Ellison and others in our organization built a monoclonal antibody that would inhibit the GIP receptor, recognizing that GLP one agonism can also confer favorable physiology and obesity and related conditions, we have appended two GLP-1 peptides to this antibody. Amgen bought deCode Genetics back in 2012

ClinicalTrials.gov: NCT04881760), participants receiving the highest dose of retatrutide demonstrated mean body weight reductions of approximately 24% over 48 weeks among the most significant weight-loss outcomes observed in pharmacological trials to date